User profiles for Elaine Bortoleti de Araujo

Elaine Bortoleti de Araujo

Radiopharmacy professor
Verified email at ipen.br
Cited by 368

In vitro and in vivo response of PSMA-617 radiolabeled with CA and NCA lutetium-177

…, MH Marumo, LFS Teixeira, EB de Araújo - Applied Radiation and …, 2022 - Elsevier
The PSMA-targeted radionuclide therapy has been explored since 2015 with radioisotope
lutetium-177, whose β − emission range is adequate for micrometastases treatment. This …

Anti-HER2 monoclonal antibody based-radioimmunoconjugates: Assessment of the chelating agent influence

…, CR de Lima, E Perini, EB de Araújo - Bioorganic & Medicinal …, 2021 - Elsevier
In the present work, the radioimmunoconjugates 111 In-DTPA-trastuzumab and 177 Lu-DOTA-trastuzumab
were evaluated regarding the influence of the chelating agents on the …

[HTML][HTML] Radiolabeling and biodistribution of monoclonal antibody (MAb) anti-CD20 with iodine-131

…, JS Caldeira Filho, RM Couto, EB Araújo - Brazilian Archives of …, 2005 - SciELO Brasil
Radioactive isotopes of iodine, mainly iodine-131 have been broadly used in many monoclonal
antibody radioiodination settings, employing different methods. In this study, using a …

[HTML][HTML] Development of radioimmunoconjugate for diagnosis and management of head-and-neck subclinical cancer and colorectal carcinoma

…, JJ Silva, CAWV Boas, J Mengatti, EB Araújo - Brazilian Journal of …, 2017 - SciELO Brasil
Scientific innovations in diagnostic methods are important drivers of cancer control and
prevention. Noninvasive imaging of the epidermal growth factor receptor (EGFR) in head-and-…

[HTML][HTML] Radioimmunotheranostic pair based on the anti-HER2 monoclonal antibody: Influence of chelating agents and radionuclides on biological properties

…, MH Bellini, MICC Guimarães, EB de Araújo - Pharmaceutics, 2021 - mdpi.com
The oncogene HER2 is an important molecular target in oncology because it is associated
with aggressive disease and the worst prognosis. The development of non-invasive imaging …

[HTML][HTML] Garantia da qualidade aplicada à produção de radiofármacos

EB Araújo, T Lavinas, MT Colturato… - Revista Brasileira de …, 2008 - SciELO Brasil
ARAÚJO, EB Conjunto de reativos liofilizados de compostos diaminoditiólicos para
marcação com tecnécio-99m. Estudo farmacocinético e elaboração de modelos …

Stability in the Production and Transport of 177Lu Labelled PSMA

…, LAP Dias, MMN Matsuda, EB de Araújo - Brazilian Journal of …, 2021 - sbpr.org.br
The prostate cancer is the second most prevalent disease among men in Brazil, moreover
PSMA therapy could change this scenario and its perspectives. IPEN-CNEN is the Brazilian …

[HTML][HTML] Comparative overview of innovation and patent filings in Radiopharmacy

ACC Miranda, DR Lobato, EB Araújo - Einstein (São Paulo), 2019 - SciELO Brasil
Objective To expose the current situation of the Brazilian Nuclear Medicine in relation to
innovation, taking into account the Intellectual Property protection and the particularities of this …

[PDF][PDF] 2 FARMACOPEIA BRASILEIRA

…, CFD Garrote, AA de Souza Araújo… - Formulário de …, 2021 - fitoterapiabrasil.com.br
Todos os insumos empregados na elaboração das formulações relacionadas nesse formulário
devem, obrigatoriamente, cumprir com as especificações de qualidade, descritas na …

[HTML][HTML] Comparative biodistribution profile of [131I] VIP and [131I] VIP10-28

MT Colturato, E Muramoto, EB Araújo - Brazilian Archives of Biology …, 2005 - SciELO Brasil
Various tumor cells express significantly higher amounts of VIP receptors (VIPR) that provided
the basis for the clinical use of radiolabeled VIP for the in vivo localization of tumors. This …